| Trisha M Bruns, | |
|
100 Michigan St Ne, Grand Rapids, MI 49503-2560 | |
| (616) 391-1751 | |
| Not Available |
| Full Name | Trisha M Bruns |
|---|---|
| Gender | Female |
| Speciality | Certified Nurse Midwife (cnm) |
| Experience | 10 Years |
| Location | 100 Michigan St Ne, Grand Rapids, Michigan |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1568862654 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367A00000X | Advanced Practice Midwife | 0024171996 (Virginia) | Secondary |
| 367A00000X | Advanced Practice Midwife | 4704328660 (Michigan) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Spectrum Health Hospitals | 8921904764 | 131 |
News Archive
For the first time, more than 40,000 IBD patients, researchers, and healthcare providers will be brought together by IBD Plexus to create the world's largest registry of IBD patients of all ages which will transform how IBD research is being conducted.
Researchers from A*STAR Institute of Microelectronics (IME) have developed a lateral silicon-based drug screening tool that has demonstrated simultaneous capture of 12 individual cells – 12 times higher throughput than conventional patch clamping. The device can be scaled up to allow 1536 cell-recordings simultaneously, permitting 16 times higher throughput than existing planar patch clamp approach.
In a first-of-its-kind study, scientists are reporting that the indoor air in offices is an important source of worker exposure to potentially toxic substances released by carpeting, furniture, paint and other items. Their report, which documents a link between levels of these so-called polyfluorinated compounds (PFCs) in office air and in the blood of workers, appears in ACS' journal Environmental Science & Technology.
GlaxoSmithKline today announced that the United States Food and Drug Administration granted full approval for PROMACTA, an oral tablet that can raise platelet counts in patients with the rare blood disorder chronic immune thrombocytopenic purpura who have had an insufficient response to corticosteroids, immunoglobulins or splenectomy.
CareFirst BlueCross BlueShield, the largest insurer in the Maryland, Washington and Northern Virginia market, will begin offering financial rewards to physicians who improve quality while cutting costs. Beginning on Jan. 1, the insurer plans to recruit doctors "to participate in its new initiative designed to cut down on the number of unnecessary diagnostic tests, emergency room visits and hospital re-admissions. To do so, CareFirst is putting the onus on the 5,000 doctors already in its network to revamp the care provided to their patients — particularly those with chronic diseases or at risk of contracting them — and more carefully consider where they send patients when they need to see a specialist or go to the hospital."
› Verified 4 days ago
| Entity Name | Spectrum Health Primary Care Partners |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235188673 PECOS PAC ID: 4587568647 Enrollment ID: O20031121000091 |
News Archive
For the first time, more than 40,000 IBD patients, researchers, and healthcare providers will be brought together by IBD Plexus to create the world's largest registry of IBD patients of all ages which will transform how IBD research is being conducted.
Researchers from A*STAR Institute of Microelectronics (IME) have developed a lateral silicon-based drug screening tool that has demonstrated simultaneous capture of 12 individual cells – 12 times higher throughput than conventional patch clamping. The device can be scaled up to allow 1536 cell-recordings simultaneously, permitting 16 times higher throughput than existing planar patch clamp approach.
In a first-of-its-kind study, scientists are reporting that the indoor air in offices is an important source of worker exposure to potentially toxic substances released by carpeting, furniture, paint and other items. Their report, which documents a link between levels of these so-called polyfluorinated compounds (PFCs) in office air and in the blood of workers, appears in ACS' journal Environmental Science & Technology.
GlaxoSmithKline today announced that the United States Food and Drug Administration granted full approval for PROMACTA, an oral tablet that can raise platelet counts in patients with the rare blood disorder chronic immune thrombocytopenic purpura who have had an insufficient response to corticosteroids, immunoglobulins or splenectomy.
CareFirst BlueCross BlueShield, the largest insurer in the Maryland, Washington and Northern Virginia market, will begin offering financial rewards to physicians who improve quality while cutting costs. Beginning on Jan. 1, the insurer plans to recruit doctors "to participate in its new initiative designed to cut down on the number of unnecessary diagnostic tests, emergency room visits and hospital re-admissions. To do so, CareFirst is putting the onus on the 5,000 doctors already in its network to revamp the care provided to their patients — particularly those with chronic diseases or at risk of contracting them — and more carefully consider where they send patients when they need to see a specialist or go to the hospital."
› Verified 4 days ago
| Entity Name | Spectrum Health Hospitals |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558407189 PECOS PAC ID: 8921904764 Enrollment ID: O20040120000997 |
News Archive
For the first time, more than 40,000 IBD patients, researchers, and healthcare providers will be brought together by IBD Plexus to create the world's largest registry of IBD patients of all ages which will transform how IBD research is being conducted.
Researchers from A*STAR Institute of Microelectronics (IME) have developed a lateral silicon-based drug screening tool that has demonstrated simultaneous capture of 12 individual cells – 12 times higher throughput than conventional patch clamping. The device can be scaled up to allow 1536 cell-recordings simultaneously, permitting 16 times higher throughput than existing planar patch clamp approach.
In a first-of-its-kind study, scientists are reporting that the indoor air in offices is an important source of worker exposure to potentially toxic substances released by carpeting, furniture, paint and other items. Their report, which documents a link between levels of these so-called polyfluorinated compounds (PFCs) in office air and in the blood of workers, appears in ACS' journal Environmental Science & Technology.
GlaxoSmithKline today announced that the United States Food and Drug Administration granted full approval for PROMACTA, an oral tablet that can raise platelet counts in patients with the rare blood disorder chronic immune thrombocytopenic purpura who have had an insufficient response to corticosteroids, immunoglobulins or splenectomy.
CareFirst BlueCross BlueShield, the largest insurer in the Maryland, Washington and Northern Virginia market, will begin offering financial rewards to physicians who improve quality while cutting costs. Beginning on Jan. 1, the insurer plans to recruit doctors "to participate in its new initiative designed to cut down on the number of unnecessary diagnostic tests, emergency room visits and hospital re-admissions. To do so, CareFirst is putting the onus on the 5,000 doctors already in its network to revamp the care provided to their patients — particularly those with chronic diseases or at risk of contracting them — and more carefully consider where they send patients when they need to see a specialist or go to the hospital."
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Trisha M Bruns, 100 Michigan St Ne # Mc845, Grand Rapids, MI 49503-2560 Ph: () - | Trisha M Bruns, 100 Michigan St Ne, Grand Rapids, MI 49503-2560 Ph: (616) 391-1751 |
News Archive
For the first time, more than 40,000 IBD patients, researchers, and healthcare providers will be brought together by IBD Plexus to create the world's largest registry of IBD patients of all ages which will transform how IBD research is being conducted.
Researchers from A*STAR Institute of Microelectronics (IME) have developed a lateral silicon-based drug screening tool that has demonstrated simultaneous capture of 12 individual cells – 12 times higher throughput than conventional patch clamping. The device can be scaled up to allow 1536 cell-recordings simultaneously, permitting 16 times higher throughput than existing planar patch clamp approach.
In a first-of-its-kind study, scientists are reporting that the indoor air in offices is an important source of worker exposure to potentially toxic substances released by carpeting, furniture, paint and other items. Their report, which documents a link between levels of these so-called polyfluorinated compounds (PFCs) in office air and in the blood of workers, appears in ACS' journal Environmental Science & Technology.
GlaxoSmithKline today announced that the United States Food and Drug Administration granted full approval for PROMACTA, an oral tablet that can raise platelet counts in patients with the rare blood disorder chronic immune thrombocytopenic purpura who have had an insufficient response to corticosteroids, immunoglobulins or splenectomy.
CareFirst BlueCross BlueShield, the largest insurer in the Maryland, Washington and Northern Virginia market, will begin offering financial rewards to physicians who improve quality while cutting costs. Beginning on Jan. 1, the insurer plans to recruit doctors "to participate in its new initiative designed to cut down on the number of unnecessary diagnostic tests, emergency room visits and hospital re-admissions. To do so, CareFirst is putting the onus on the 5,000 doctors already in its network to revamp the care provided to their patients — particularly those with chronic diseases or at risk of contracting them — and more carefully consider where they send patients when they need to see a specialist or go to the hospital."
› Verified 4 days ago
Courtney Tamburello Hilbert, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 100 Michigan St Ne # Mc020, Grand Rapids, MI 49503 Phone: 616-391-2160 | |
Jennifer Marie Shanley, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 426 Michigan St Ne, Grand Rapids, MI 49503 Phone: 616-391-3302 | |
Carolyn E Leja, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 100 Michigan St Ne # Mc020, Grand Rapids, MI 49503 Phone: 616-391-1751 | |
Mariel Christine Haverdink, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 80 68th St Se Ste 301, Grand Rapids, MI 49548 Phone: 616-391-3302 | |
Erin Irwin, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 100 Michigan St Ne, Grand Rapids, MI 49503 Phone: 616-391-2160 | |
Laurel Patricia Jessup, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 100 Michigan St Ne # Mc027, Grand Rapids, MI 49503 Phone: 616-391-2160 | |
Renee M Bates, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 100 Michigan St Ne, Mc 020, Grand Rapids, MI 49503 Phone: 616-391-1751 Fax: 616-391-2310 |